NEWS

What China's Manufacturing Strength Means for Long-Term Oxygen System Reliability and Global Healthcare Infrastructure

Key Takeaways

• China is now one of the largest global manufacturing hubs for PSA oxygen systems, with strong export penetration across emerging and developed healthcare markets.
• Procurement decisions are shifting from price comparison to manufacturing depth and engineering ownership.
• Long-term oxygen stability depends more on manufacturing precision than on initial technical specifications.
• Integrated manufacturing reduces cumulative tolerances and improves lifecycle consistency.
• Manufacturers like ZOY Technology represent a new model of full-stack oxygen system production.

Why is China becoming a major global hub for PSA oxygen manufacturing?

China has become a core global production base for PSA oxygen systems.

According to publicly available trade and medical equipment industry reports (including UN Comtrade and market research datasets such as Fortune Business Insights and Mordor Intelligence), Asia—led by China—now accounts for a significant and growing share of global medical oxygen equipment manufacturing and export supply.

But cost is no longer the main driver.

Global hospitals now choose Chinese manufacturers for three structural reasons:

• Strong engineering capability behind system design
• High-volume manufacturing consistency
• Proven ability to deliver across complex international healthcare environments

Modern procurement has shifted.Buyers no longer ask only “what equipment to buy.”
They now ask “who built this system, and how it was engineered.”

Why do similar PSA oxygen systems behave differently over long-term operation?

Product specifications define what a system can do on day one. Manufacturing capability defines whether it can still do it ten years later. Two PSA oxygen systems may show identical oxygen purity and flow rate in initial tests. But long-term performance often diverges. The reason is not external use—it is internal manufacturing tolerance.

Key factors include:

• Sieve bed compaction uniformity
• Airflow distribution accuracy
• Pneumatic valve transient response
• Thermodynamic stability under continuous load
• Welding precision in pressure systems
• Cumulative tolerance stacking across subsystems

In PSA systems, even a 1–2% deviation in airflow distribution can compound over tens of thousands of cycles. This leads to measurable differences in purity stability and energy efficiency over time.

Manufacturing precision is not a secondary parameter.
It is the system itself.

What defines a modern integrated PSA oxygen manufacturer?

The difference between assembly factories and integrated manufacturers is structural, not cosmetic.

Dimension	Traditional Assembly Model	Integrated Manufacturing Model
Core Structure	Supply chain assembly	Full-stack internal system
Engineering Design	External drawings	Independent mechanical, electrical, PLC design
Production Control	Multi-vendor dependency	Single-system quality control
Traceability	Fragmented	End-to-end lifecycle tracking
System Output	Equipment assembly	Engineering-driven oxygen systems

Integrated manufacturers control the full chain:

• Industrial design
• Mechanical engineering
• Electrical system design
• PLC control development
• In-house fabrication and assembly
• Full performance testing

As a representative of this modern integrated approach, ZOY TECH has moved beyond the traditional assembly-only model. From system design and PLC programming to final assembly, every key stage is managed in-house. This integrated structure reduces variation between suppliers and improves long-term system stability in real hospital environments.

Where does long-term oxygen system reliability actually come from?

Long-term reliability is not created during installation. It is built during design and manufacturing.

PSA oxygen systems operate under continuous pressure cycles, thermal variation and airflow fluctuation. Stability depends on system-level engineering, not isolated components.

Core engineering mechanisms include:

• Dynamic energy regulation under fluctuating hospital demand
• Heat recovery systems that reuse compressor waste energy
• Predictive maintenance based on operational data models
• PLC-based adaptive pressure and purity control
• Modular oxygen generation architecture for load balancing

These mechanisms work together as one system. Over time, they evolve into proprietary engineering IP. In ZOY Technology’s case, this development process has resulted in 13 core invention patents, covering system control, energy optimization and integrated oxygen generation architecture.

Patents are not the starting point. They are the result of long-term engineering iteration.

How does global project experience improve manufacturing capability?

Each project introduces different engineering challenges.

ZOY Technology has delivered oxygen infrastructure across more than 60 countries and 2,000 healthcare facilities, while also participating in demanding projects such as the Ali region in Tibet, Hongyuan County on the Sichuan Plateau, and the New Sichuan–Tibet Railway.

These environments continuously refine manufacturing capability:

·  Ali, Tibet → optimized compressor intake, PLC compensation algorithms and oxygen production efficiency for high-altitude, low-pressure environments.

·  Hongyuan County, Sichuan → enhanced thermal management and system stability under large day–night temperature fluctuations.

·  New Sichuan–Tibet Railway → strengthened modular integration, vibration resistance and long-term reliability for plateau infrastructure with limited maintenance access.

·  Sub-Saharan Africa → improved moisture protection, multi-stage air filtration and corrosion resistance for hot, humid operating conditions.

·  Regions with unstable power supply → integrated photovoltaic (PV)-compatible power solutions, intelligent energy management and fault-tolerant control to ensure continuous oxygen production during grid instability.

Every project generates engineering data. Every engineering improvement returns to manufacturing. This continuous feedback loop transforms field experience into product innovation, allowing each new generation of oxygen systems to perform more reliably than the last.

How can buyers identify a true source PSA oxygen manufacturer?

In global procurement, surface specifications are no longer sufficient. Real evaluation must focus on manufacturing ownership and engineering depth.

The Hidden Procurement Checklist

• Does the manufacturer own PLC control system development?
• Is mechanical and electrical design fully in-house?
• Are pressure vessels and core components manufactured internally and tested?
• Does the company hold invention-level patents rather than only design upgrades?
• Is ISO 13485 or equivalent medical quality system implemented?
• Does the system support IoT-based remote monitoring and predictive maintenance?
• Does the manufacturer have verified multi-region deployment experience?

A supplier that meets these conditions is not an assembler. It is a manufacturing system owner.

Ending

The global oxygen infrastructure market is undergoing structural change. Chinese PSA oxygen manufacturers are no longer only equipment exporters. They are becoming system-level participants in global healthcare infrastructure. Manufacturing capability is now a primary factor in procurement decisions, alongside cost and specification. In this shift, selecting a manufacturer is no longer a purchasing action.It is a long-term infrastructure decision.

About ZOY Technology

Founded in 2015 and headquartered in Changsha, China, ZOY Technology specializes in oxygen generation technologies for healthcare and industrial applications. The company integrates research and development, manufacturing, installation, and after-sales service to deliver complete oxygen supply solutions.

Its product portfolio includes PSA medical oxygen generation systems, centralized oxygen supply solutions, integrated oxygen generation stations, industrial oxygen systems, and hyperbaric oxygen chambers. Today, ZOY Technology systems support more than 2,000 healthcare facilities and have been exported to over 60 countries worldwide.

With a strong focus on innovation, ZOY Technology holds multiple core invention patents and continues to invest in advanced oxygen generation technologies. Its solutions have been deployed in hospitals, emergency response projects, railway infrastructure, hospital ships, and regional oxygen supply programs, helping customers build safer, more reliable, and more efficient oxygen supply systems.

By combining scalable system design with long-term operational reliability, ZOY Technology supports healthcare facilities and industrial users throughout every stage of oxygen infrastructure development.